These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 3567258)

  • 1. Increased plasma phospholipase-A2 activity in schizophrenic patients: reduction after neuroleptic therapy.
    Gattaz WF; Köllisch M; Thuren T; Virtanen JA; Kinnunen PK
    Biol Psychiatry; 1987 Apr; 22(4):421-6. PubMed ID: 3567258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Possible involvement of phospholipase A2 in the pathogenesis of schizophrenia].
    Gattaz WF; Nevalainen TJ; Kinnunen PK
    Fortschr Neurol Psychiatr; 1990 Apr; 58(4):148-53. PubMed ID: 2354835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased serum phospholipase A2 activity in schizophrenia: a replication study.
    Gattaz WF; Hübner CV; Nevalainen TJ; Thuren T; Kinnunen PK
    Biol Psychiatry; 1990 Sep; 28(6):495-501. PubMed ID: 2223919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated PLA2 activity in schizophrenics and other psychiatric patients.
    Noponen M; Sanfilipo M; Samanich K; Ryer H; Ko G; Angrist B; Wolkin A; Duncan E; Rotrosen J
    Biol Psychiatry; 1993 Nov; 34(9):641-9. PubMed ID: 8292693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Accelerated breakdown of membrane phospholipids in schizophrenia--implications for the hypofrontality hypothesis].
    Gattaz WF; Brunner J; Schmitt A; Maras A
    Fortschr Neurol Psychiatr; 1994 Dec; 62(12):489-96. PubMed ID: 7835820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased phospholipid breakdown in schizophrenia. Evidence for the involvement of a calcium-independent phospholipase A2.
    Ross BM; Hudson C; Erlich J; Warsh JJ; Kish SJ
    Arch Gen Psychiatry; 1997 May; 54(5):487-94. PubMed ID: 9152103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phospholipase A2 activity in serum of neuroleptic-naive psychiatric inpatients.
    Albers M; Meurer H; Märki F; Klotz J
    Pharmacopsychiatry; 1993 May; 26(3):94-8. PubMed ID: 8415900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased phospholipase A2 activity in schizophrenia with absent response to niacin.
    Tavares H; Yacubian J; Talib LL; Barbosa NR; Gattaz WF
    Schizophr Res; 2003 May; 61(1):1-6. PubMed ID: 12648730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased platelet phospholipase A2 activity in schizophrenia.
    Gattaz WF; Schmitt A; Maras A
    Schizophr Res; 1995 Jul; 16(1):1-6. PubMed ID: 7547640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased calcium-independent phospholipase A2 activity in first but not in multiepisode chronic schizophrenia.
    Smesny S; Kinder D; Willhardt I; Rosburg T; Lasch J; Berger G; Sauer H
    Biol Psychiatry; 2005 Feb; 57(4):399-405. PubMed ID: 15705356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between BanI genotype and increased phospholipase A2 activity in schizophrenia.
    Barbosa NR; Junqueira RM; Vallada HP; Gattaz WF
    Eur Arch Psychiatry Clin Neurosci; 2007 Sep; 257(6):340-3. PubMed ID: 17629734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Erythrocyte ketone reductase activity, total plasma haloperidol and acute psychoses].
    Dutoit D; Thomas P; Leroux JM; Vaiga G; Pommery J; Cottencin O; Erb F; Goudemand M
    Encephale; 1995; 21(6):417-24. PubMed ID: 8674466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phospholipase A2 activity in Epstein-Barr virus-transformed lymphoblast cells from schizophrenic patients.
    Bennett ER; Yedgar S; Lerer B; Ebstein RP
    Biol Psychiatry; 1991 Jun; 29(11):1058-62. PubMed ID: 1651772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracerebral injection of phospholipase A2 inhibits dopamine-mediated behavior in rats: possible implications for schizophrenia.
    Brunner J; Gattaz WF
    Eur Arch Psychiatry Clin Neurosci; 1995; 246(1):13-6. PubMed ID: 8773214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoreactive pancreatic phospholipase A2 and catalytically active phospholipases A2 in serum from patients with acute pancreatitis.
    Eskola JU; Nevalainen TJ; Kortesuo P
    Clin Chem; 1988 Jun; 34(6):1052-4. PubMed ID: 3288372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential alteration of phospholipase A2 activities in brain of patients with schizophrenia.
    Ross BM; Turenne S; Moszczynska A; Warsh JJ; Kish SJ
    Brain Res; 1999 Mar; 821(2):407-13. PubMed ID: 10064828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasopressin--oxytocin in cerebrospinal fluid of schizophrenic patients and normal controls.
    Beckmann H; Lang RE; Gattaz WF
    Psychoneuroendocrinology; 1985; 10(2):187-91. PubMed ID: 4034849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated plasma phospholipase A2 levels: correlation with the hemodynamic and pulmonary changes in gram-negative septic shock.
    Vadas P
    J Lab Clin Med; 1984 Dec; 104(6):873-81. PubMed ID: 6548766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Value of neuroleptic therapy in the self assessment of schizophrenic patients].
    Heim M
    Psychiatr Neurol Med Psychol (Leipz); 1987 Aug; 39(8):487-91. PubMed ID: 3685210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroleptic effects on serine and glycine metabolism.
    Baruah S; Waziri R; Sherman A
    Biol Psychiatry; 1993 Oct; 34(8):544-50. PubMed ID: 7903868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.